NAO VNS
LIVE

Serial Number

79268962

Owner

Synergia Medical SA

Attorney

Lynne Boisineau

Filing Date

Sep 5, 2019

Add to watchlist:

No watchlists yet
View on USPTO

NAO VNS Trademark

Serial Number: 79268962 • Registration: 6082478

NAO VNS is a trademark filed by Synergia Medical SA on September 5, 2019. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Synergia Medical SA (10 trademarks)

Rue Emile Francqui 6

Entity Type: 33

Trademark Details

Filing Date

September 5, 2019

Registration Date

June 23, 2020

Published for Opposition

April 7, 2020

Goods & Services

Electronic neurostimulators for medical use

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 23, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jan 8, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 2, 2020 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Oct 15, 2020 FICS
FINAL DISPOSITION PROCESSED
Oct 15, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 23, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 23, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2020 CRFA
ASSIGNED TO LIE
Mar 2, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2020 TROA
REFUSAL PROCESSED BY IB
Jan 31, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 11, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jan 10, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 12, 2019 RFCR
NON-FINAL ACTION WRITTEN
Dec 11, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 15, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 11, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 10, 2019 REPR